Stock & Company Details
Allarity Therapeutics Inc $ALLR
Price:
N/A
N/A
16M
$22M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.95
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALLR technical indicators
Latest Allarity Therapeutics Inc (ALLR) indicator readings as of 2026-08-28.
ALLR's 14-day RSI is 57.2, in neutral territory. At $1.41 it is trading 14.3% above its 200-day moving average of $1.23, and above its 50-day average of $1.29. Price sits in the middle of its Bollinger Bands ($1.29 to $1.46). ADX reads 15.8, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Finance Bot
Ask your questions
Start by typing a question below.
